Lymphosarcoma  >>  Halaven (eribulin mesylate)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Halaven (eribulin mesylate) / Eisai
BOLD 113, NCT02171260 / 2016-001894-34: This is a Phase 1 Study of Eribulin Mesylate in Pediatric Participants With Recurrent or Refractory Solid Tumors (Excluding [Central Nervous System] CNS), Including Lymphomas

Completed
1
23
US
Eribulin Mesylate, E7389
Eisai Inc., Children's Oncology Group
Pediatrics, Solid Tumors
01/16
01/16

Download Options